Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05568498 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

Study acronym: ProD
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 30, 2026 to Dec 31, 2027
    • Eligibility criteria shortened, about 34 words
    • Secondary endpoints: details revised at 6 of 7 entries
    • Study description expanded, about 125 words
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 8 more changesShow less
    • Primary completion date: Oct 30, 2024 to Dec 30, 2026
    • Start date changed from estimate of Oct 30, 2022 to Jan 20, 2025
    • Primary endpoints: 1 to 3
    • Study sites: 0 to 1
    • Study completion date: Oct 30, 2026 to Dec 30, 2026
    • Eligibility criteria shortened, about 128 words
    • Secondary endpoints: 6 to 7
    • Study description shortened, about 9 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluates the use of an oral multi-strain probiotic in the treatment of depression in individuals with Parkinson's Disease. Participants will be randomized to either a 12-week multi-strain probiotic treatment or placebo intervention.
Trial Details
NCT Number NCT05568498
Lead Sponsor University of British Columbia
Conditions
(from sponsor)		 Parkinson Disease, Depression, PARKINSON DISEASE (Disorder)
Related terms Depression, Parkinson Disease
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov